| Literature DB >> 35818428 |
Wooram Choi1, Hyun Soo Kim2, Sang Hee Park3, Donghyun Kim2, Yong Deog Hong2, Ji Hye Kim1, Jae Youl Cho1,3.
Abstract
Background: In aged skin, reactive oxygen species (ROS) induces degradation of the extracellular matrix (ECM), leading to visible aging signs. Collagens in the ECM are cleaved by matrix metalloproteinases (MMPs). Syringaresinol (SYR), isolated from Panax ginseng berry, has various physiological activities, including anti-inflammatory action. However, the anti-aging effects of SYR via antioxidant and autophagy regulation have not been elucidated.Entities:
Keywords: 3-MA, 3-Methyladenine; ABTS, 2,2′-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid; Anti-aging; Antioxidant; Autophagy; CMA, chaperone-mediated autophagy; DMEM, Dulbecco's Modified Eagle's medium; DMSO, dimethyl sulfoxide; DPPH, 2,2 diphenyl-1-picrylhydrazyl; ECM, extracellular matrix; FBS, fetal bovine serum; FoxO3a, Forkhead box O3; MAPK, mitogen-activated protein kinase; MMP, matrix metalloproteinase; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; Panax ginseng berry; ROS, reactive oxygen species; SYR, Syringaresinol; Syringaresinol; UV, ultraviolet
Year: 2021 PMID: 35818428 PMCID: PMC9270644 DOI: 10.1016/j.jgr.2021.08.003
Source DB: PubMed Journal: J Ginseng Res ISSN: 1226-8453 Impact factor: 5.735
Fig. 1Anti-aging activity of SYR in HaCaT cells. (A) Chemical structure of syringaresinol and 3-Methyladenin (Left panel) and analysis profile of syringaresinol by HPLC (Right panel). (B, C, and D) Following SYR (100 and 200 μg/mL) treatment, HaCaT cells were incubated with H2O2 (500 μM) for 24 h mRNA levels of MMP-2 (B) and MMP-9 (C) were determined by real-time PCR. Protein levels of MMP-2 and MMP-9 were measured by Western blotting (D). (E) HaCaT cells were treated with various concentrations (0–200 μg/mL) of SYR and then incubated for 24 h. Protein levels of MMP-2 and MMP-9 were determined by immunoblotting analysis. (F) Viability of SYR-treated HaCaT cells was measured by MTT assay. p < 0.05 and p < 0.01 compared with the normal group; ∗p < 0.05 and ∗∗p < 0.01 compared with the control group.
Primer list used in this study.
| Gene | Direction | Sequences |
|---|---|---|
| F | CAAGTGGAGAGCAGTTGAGGACATC | |
| R | TGAGGACATCTCCCACGTCAA | |
| F | GCCACTTGTCGGCGATAAGG | |
| R | CACTGTCCACCCCTCAGAGC | |
| F | CACTCACGGCAAATTCAACGGCA | |
| R | GACTCCACGACATACTCAGCAC |
F: Forward, R: Reverse.
Fig. 2Antioxidant activity of SYR. (A) DPPH and SYR (0–200 μg/mL) were incubated together at 37 °C for 30 min. Absorbance at 517 nm was measured by spectrophotometry. (B) SYR (0–200 μg/mL) was mixed with ABST in the dark at 37 °C for 30 min. Absorbance at 730 nm was observed by spectrophotometry. ∗p < 0.05 and ∗∗p < 0.01 compared with the control group.
Fig. 3Effect of SYR on autophagy activation. (A) SYR (100 and 200 μg/mL)-treated HaCaT cells were incubated with H2O2 for 12 h. Then, the total level of LC3B was determined by Western blotting. β-Actin was used as a loading control. (B) HaCaT cells were treated with SYR (50, 100, and 200 μg/mL) for 24 h, and then the total levels of LC3B and β -actin were determined by immunoblotting analysis. (C and D) HaCaT cells were transfected with a plasmid expressing GFP-LC3B and incubated with 200 μg/mL SYR and H2O2 for 12 h (C). HaCaT cells were transfected with plasmid GFP-LC3B and incubated with 200 μg/mL SYR for 24 h (D). Confocal microscopy images were observed using a laser-scanning confocal microscope (Zeiss LSM 710 META). p < 0.05 and p < 0.01 compared with the normal group; ∗p < 0.05 and ∗∗p < 0.01 compared with the control group.
Fig. 4Relevance of autophagy activation to the anti-aging activity of SYR. (A and B) HaCaT cells were incubated with H2O2 (500 μM) in the presence or absence of SYR (200 μg/mL) or 3-MA (5 mM) for 24 h (A). HaCaT cells were treated with SYR (200 μg/mL) in the presence or absence of 3-MA (5 mM) for 24 h (B). The expression of MMP-2 and β-actin was determined by Western blotting. p < 0.05 and p < 0.01 compared with the normal group; ∗p < 0.05 and ∗∗p < 0.01 compared with the control group; ns, not significant.
Fig. 5Schematic summary of the anti-aging effects of SYR and its mechanisms.